The effect of an enhanced antenatal care package for the control of malaria and anaemia in pregnancy in Ghana
Completed
- Conditions
- 1. Malaria2. AnaemiaPregnancy and Childbirth
- Registration Number
- ISRCTN88917252
- Lead Sponsor
- Department of Global and International Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 1663
Inclusion Criteria
1. Pregnant woman visiting the antenatal clinic for the first time for the current pregnancy
2. Up to 32 weeks gestation at booking
3. Haermoglobin = 7g/dl at booking
4. Within the catchment area of the health facility
Exclusion Criteria
1. Pregnant woman with a history or presence of any systemic illness likely to interfere with interpretation of trial results e.g. HIV-AIDS, sickle cell disease, G-6PD deficiency
2. Pregnant woman with any significant illness at time of screening that required hospitalization (including severe anaemia)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Prevalence of malaria parasitaemia at 4-8 weeks after enrollment<br>2. Prevalence of anaemia 4-8 weeks after enrollment<br>
- Secondary Outcome Measures
Name Time Method 1. Prevalence of malaria parasitaemia prior to delivery<br>2. Prevalence of anaemia prior to delivery<br>3. Prevalence of low birth weight<br>4. Prevalence of sub-optimal pregnancy outcomes (still births, abortions, miscarriages)<br>5. Level of pregnant women's knowledge about malaria and anaemia in pregnancy<br>6. Level of pregnant women's adherence to health advice<br>7. Feasibility and acceptability of the use of HCS and RDT during antenatal care